add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News

November 7, 2011

Accentia has $10 million deal to sell Analytica

Filed under: Other Regional News — admin @ 3:43 pm

TAMPA, FL - Accentia Biopharmaceuticals Inc. agreed to sell the assets of its Analytica International Inc. business unit for up to $10 million to LA-SER Alpha Group Sarl.

The sale is part of a series of deals Accentia plans to strengthen its financial position, improve its balance sheet and support ongoing biotech development plans, a company statement said.

Ancor buys WellSpring Pharmaceutical

Filed under: Other Regional News — admin @ 3:39 pm

SARASOTA, FL - Ancor Capital Partners acquired WellSpring Pharmaceutical Corp.WellSpring, based in Sarasota and in Toronto, is a manufacturer and marketer of specialty prescription and over-the-counter products, and offers contract manufacturing.

Financial terms of the acquisition were not disclosed in a statement announcing the deal.

November 4, 2011

N.C. ‘Accelerator’ to invest $35M in early-stage life science companies

Filed under: Regional Venture News — admin @ 12:13 pm

RALEIGH, NC - Early-stage life science companies have long grumbled about the ability to secure financing and those grumbles have only grown louder given the market conditions that have dried up many financing options.The state of North Carolina will now provide another way for life science companies to slake their thirst for capital. State Treasurer Janet Cowell will invest up to $35 million from the state’s pension fund to support early-stage life science companies in the state. Cowell formally announced the “Accelerator” at the Southeast BIO Investor Forum in Durham, North Carolina today.

October 31, 2011

Scientific Intake seeks to raise $1M

Filed under: Regional Venture News — admin @ 8:11 pm

ATLANTA, GA - An Atlanta-based medical device maker has raised more than half of a planned $1 million raise, according to a Securities & Exchange Commission filing.Scientific Intake has developed a weight loss product that helps people eat slower, thereby eating less.

People eat too quickly and eat too much before they feel full - or satisfied.

Catalyst Pharmaceutical to launch $3.5M offering

Filed under: Regional Venture News — admin @ 8:07 pm

CORAL GABLES, FL - Coral Gables-based Catalyst Pharmaceutical Partners said it plans to launch a $3.5 million stock offering, but its share price reacted negatively after the announcement.

The developmental-stage company (NASDAQ: CPRX) said it would sell 3.05 million shares of its common stock plus warrants to purchase an additional 1.52 million shares of its common stock. The price is $1.15 a share.

Medical device maker Cathtek seeks new home in Winston-Salem

Filed under: Other Regional News — admin @ 8:03 pm

WINSTOM-SALEM, NC  - Cathtek, a medical device maker, is planning to relocate to the former Curly’s Harley-Davidson dealership on Reidsville Road in Winston-Salem.

The company, which is based in the Piedmont Triad Research Park in downtown, has applied to have the dealership property rezoned from highway business to general business, according to the Winston-Salem Journal.

October 25, 2011

Inventors and investors mingle in Tampa for BioFlorida

Filed under: Other Regional News — admin @ 3:38 pm

TAMPA, FL - The life sciences industry in Florida is flourishing, despite challenges.

That’s the message Dr. Michael Schmitt, life science analyst and editor of the Florida BioDatabase, brought to the inventors, investors and other life science professionals gathered in Tampa for the annual conference of BioFlorida.

There are 171 biotech companies in the state, up 26 percent since 2008, said Schmitt, citing new data he hadn’t yet had time to post on the database. About 25 percent of them are in the Tampa Bay area.

October 24, 2011

Intrexon Acquires Immunologix, Inc.

Filed under: Other Regional News — admin @ 7:02 pm

Blacksburg, Virginia - Intrexon Corporation, a privately held synthetic biology company, today announced the acquisition of Immunologix, Inc., of Charleston, SC. Immunologix specializes in transforming naïve B-cells to produce 100% human monoclonal antibodies that can target all antigen types including, but not limited to cancer cells, viruses, bacteria, toxins, plus those epitopes related to autoimmune diseases such as diabetes, lupus, rheumatoid arthritis and multiple sclerosis. Terms of the transaction were not disclosed.

October 20, 2011

IRX Therapeutics will move to St. Peterburg, FL, bring 280 jobs in five years

Filed under: Other Regional News — admin @ 2:35 pm

ST. PETERSBURG, FL - IRX Therapeutics Inc. will relocate to St. Petersburg from New York by the end of the year.

The company said it would staff more than 280 positions within five years, at a projected minimum average wage of $90,000 annually. (more…)

October 13, 2011

Opko Health acquires Claros Diagnostics

Filed under: Other Regional News — admin @ 3:00 pm

MIAMI, FL - Opko Health has acquired Claros Diagnostics, a Woburn, Mass.-based company that has developed a novel blood testing kit for urology and infectious disease.

The Miami-based biotechnology and pharmaceutical company (NYSE: OPK) said Claros “presents an ideal strategic fit.”

Opko said it is developing unique antibody based tests for early diagnosis of Alzheimer’s disease; Parkinson’s disease; and lung, pancreatic and other cancers.

“The combined Opko-Claros technology will also provide an ideal platform for use as companion diagnostics,” the company stated.

Last month, Opko Health signed a deal to sell its ophthalmic instrumentation business to OPTOS for $17.5 million, plus future royalties.

Opko shares were down 13 cents to $4.68 in morning trading. The 52-week high was $5.03 on Feb. 16. The 52-week low was $2.41 on Oct. 18, 2010.

« Previous PageNext Page »